- New Purchases: AAPL, XTNT,
- Added Positions: IBM, MRK, VRX, ABBV, PFE, AGN, ABT,
- Reduced Positions: ASTC, ACTA,
- Sold Out: CPN, AGEN,
For the details of Robert Bruce's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Robert+Bruce
These are the top 5 holdings of Robert Bruce- Amerco Inc (UHAL) - 185,969 shares, 14.49% of the total portfolio.
- NextEra Energy Inc (NEE) - 243,200 shares, 8.97% of the total portfolio.
- Allstate Corp (ALL) - 333,800 shares, 7.15% of the total portfolio.
- Duke Energy Corp (DUK) - 347,788 shares, 6.08% of the total portfolio.
- AbbVie Inc (ABBV) - 271,915 shares, 5.81% of the total portfolio. Shares added by 16.74%
Bruce & Co. initiated holding in Apple Inc. The purchase prices were between $155.15 and $181.72, with an estimated average price of $172.19. The stock is now traded at around $186.44. The impact to a portfolio due to this purchase was 3.23%. The holding were 85,300 shares as of 2018-03-31.
New Purchase: Xtant Medical Holdings Inc (XTNT)Bruce & Co. initiated holding in Xtant Medical Holdings Inc. The purchase prices were between $4.62 and $9.75, with an estimated average price of $6.59. The stock is now traded at around $6.44. The impact to a portfolio due to this purchase was 0.53%. The holding were 296,172 shares as of 2018-03-31.
Added: International Business Machines Corp (IBM)Bruce & Co. added to a holding in International Business Machines Corp by 37.56%. The purchase prices were between $147.59 and $169.12, with an estimated average price of $158.26. The stock is now traded at around $143.74. The impact to a portfolio due to this purchase was 1.39%. The holding were 146,500 shares as of 2018-03-31.
Added: Merck & Co Inc (MRK)Bruce & Co. added to a holding in Merck & Co Inc by 38.55%. The purchase prices were between $53.41 and $62.07, with an estimated average price of $56.63. The stock is now traded at around $59.20. The impact to a portfolio due to this purchase was 1.23%. The holding were 359,400 shares as of 2018-03-31.
Added: Valeant Pharmaceuticals International Inc (VRX)Bruce & Co. added to a holding in Valeant Pharmaceuticals International Inc by 42.74%. The purchase prices were between $14.88 and $23.87, with an estimated average price of $18.73. The stock is now traded at around $21.56. The impact to a portfolio due to this purchase was 0.92%. The holding were 855,000 shares as of 2018-03-31.
Added: Pfizer Inc (PFE)Bruce & Co. added to a holding in Pfizer Inc by 21.96%. The purchase prices were between $33.63 and $39.02, with an estimated average price of $36.23. The stock is now traded at around $35.69. The impact to a portfolio due to this purchase was 0.8%. The holding were 555,332 shares as of 2018-03-31.
Sold Out: Calpine Corp (CPN)Bruce & Co. sold out a holding in Calpine Corp. The sale prices were between $15.04 and $15.25, with an estimated average price of $15.13.
Sold Out: Agenus Inc (AGEN)Bruce & Co. sold out a holding in Agenus Inc. The sale prices were between $3.51 and $6.04, with an estimated average price of $4.53.
Here is the complete portfolio of Robert Bruce. Also check out:
1. Robert Bruce's Undervalued Stocks
2. Robert Bruce's Top Growth Companies, and
3. Robert Bruce's High Yield stocks
4. Stocks that Robert Bruce keeps buying